Essiac and Flor Essence tea: what the evidence shows

Essiac and Flor Essence are herbal tea mixtures. Essiac contains four herbs: burdock root, Indian rhubarb root, sheep sorrel and slippery elm. Flor Essence is reported to contain those same four herbs plus four others, including watercress, blessed thistle, red clover and kelp.

They are sold as dietary supplements. That legal category matters, because supplements are regulated differently from medicines and do not have to prove they work before being sold.

NCI maintains a summary on these products, and the crucial passage is short.

No reports of clinical trials of Essiac have been published in peer-reviewed scientific journals. No results of clinical studies with people of Flor Essence have been reported.

That is not a case of the evidence being weak or mixed. It is a case of the human evidence not existing in the published record.

There is one case study, involving a man with prostate cancer whose PSA level dropped. Researchers concluded that the PSA response could not be linked to Essiac. A single case, with the authors themselves unable to attribute the change, is not a foundation for a treatment decision.

Laboratory and animal studies have been done, and NCI's patient summary points readers to the professional version for detail on those. Results in cells and animals are the starting point of drug development, not the finish line. Most things that look promising in a dish do not work in people.

FDA has not approved Essiac or Flor Essence to treat cancer or any other medical condition.

Being legally sold is not the same as being shown to work. Supplements can be marketed without demonstrating benefit.

This is the single most useful thing to understand when a bottle in a shop appears to be sitting there with official permission behind it.

Herbal does not mean inert. NCI lists reported side effects.

For Essiac: nausea and vomiting.

For Flor Essence: increased bowel movements, frequent urination, swollen glands, skin blemishes, flu-like symptoms and slight headaches.

Several of these overlap with symptoms your care team would otherwise investigate. Swollen glands and flu-like symptoms during cancer treatment would normally prompt questions. If a supplement is muddying that picture, your team needs to know it is in play.

This is often the real situation. Someone who cares about you has found something they believe will help, and refusing it feels like refusing their concern.

A few things that make that easier:

• Tell your care team about anything you are considering, before you start it.
• Ask specifically about interactions with your current treatment.
• Separate the offer from the product. You can accept the love and decline the tea.
• Keep the packaging so the actual ingredient list can be checked.

The serious risk with unproven cancer products is rarely the product itself. It is what gets delayed or displaced while someone tries it. Treatment that has been shown to work is worth protecting.

It is easy to hear that phrase as a technicality, or as evidence of institutional resistance to natural remedies. It is neither.

A clinical trial is how anyone finds out whether a treatment helps, harms or does nothing. Without one, all that exists are stories, and stories select themselves. People who improve tell others. People who do not, often cannot.

That is why testimonials feel so persuasive and prove so little. Cancers vary enormously in how they behave, people take several things at once, and the treatment that was working in the background rarely gets the credit.

None of this means every untested remedy is dangerous. It means nobody, including the people selling it, actually knows whether it does anything.

If you want to try something with real evidence behind it that is not yet standard care, ask your team about clinical trials. That is precisely what they exist for, and it comes with monitoring attached.